Rapid Responses to Avapritinib (BLU-285) in Mastocytosis [News in Brief]

Targeted therapy produces lasting reductions in mast cells and molecular levels of KIT D816V.

from Cancer via ola Kala on Inoreader http://ift.tt/2APFdas
via IFTTT